The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

Additional Infant Bacterial Therapeutics product receives FDA orphan drug designation
Infectious Disease & AMR

Additional Infant Bacterial Therapeutics product receives FDA orphan drug designation

JUL 5, 2023
Adare Pharma Solutions announces divestiture of postbiotics pioneer Adare Biome to dsm-firmenich
Biotics and Supplements

Adare Pharma Solutions announces divestiture of postbiotics pioneer Adare Biome to dsm-firmenich

JUL 4, 2023
Exeliom Biosciences Announces Series A Extension and Final Closing with Total of €24 Million
Finance

Exeliom Biosciences Announces Series A Extension and Final Closing with Total of €24 Million

JUL 3, 2023
Pendulum Therapeutics Announces Strategic Partnership and $10M Investment from Fonterra
Finance

Pendulum Therapeutics Announces Strategic Partnership and $10M Investment from Fonterra

JUL 3, 2023
Concerto Biosciences Announces Discovery Initiative to Combat Recurrent Vaginal Yeast Infections
Infectious Disease & AMR

Concerto Biosciences Announces Discovery Initiative to Combat Recurrent Vaginal Yeast Infections

JUN 30, 2023
Freya Biosciences Announces Positive Topline Clinical Trial Results for FB101 in Women with Asymptomatic Vaginal Dysbiosis
Clinical & Manufacturing

Freya Biosciences Announces Positive Topline Clinical Trial Results for FB101 in Women with Asymptomatic Vaginal Dysbiosis

JUN 28, 2023
New “atlas” maps bacteria and metabolites associated with elevated risk of cardiovascular disease
Pharma & Human Health

New “atlas” maps bacteria and metabolites associated with elevated risk of cardiovascular disease

JUN 26, 2023
New biotech venture PHIOGEN, a spinoff of BCM’s TAILOR Labs
Finance

New biotech venture PHIOGEN, a spinoff of BCM’s TAILOR Labs

JUN 22, 2023
Proven Complementary Effect of Probiotic Yeast and Bacteria
Biotics and Supplements

Proven Complementary Effect of Probiotic Yeast and Bacteria

JUN 21, 2023
Azitra, Inc. Announces Closing of Initial Public Offering
Finance

Azitra, Inc. Announces Closing of Initial Public Offering

JUN 21, 2023
An oral probiotic can treat dry eye disease
Biotics and Supplements

An oral probiotic can treat dry eye disease

JUN 20, 2023